Pharmaceutical company Cytogen has closed an agreement to sell approximately three million shares of registered common stock for gross proceeds of $8 million. The Princeton, NJ-based vendor's largest shareholder, the State of Wisconsin Investment Board, purchased the shares. The proceeds will be used primarily for general corporate purposes, such as working capital and capital expenditures, according to Cytogen.
By AuntMinnie.com staff writersJanuary 23, 2002
Related Reading
Cytogen trims loss in Q3, November 7, 2001
Cytogen net loss widens in Q2 despite revenue gains, August 7, 2001
Cytogen builds executive team, June 11, 2001
Cytogen turns in revenue gains, April 27, 2001
ProstaScint scans predict prostate cancer recurrence and metastases, January 31, 2001
Copyright © 2002 AuntMinnie.com